✦ LIBER ✦

Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches

✍ Scribed by Roemer, T.; Krysan, D. J.

Book ID: 125486949
Publisher: Cold Spring Harbor Laboratory
Year: 2014
Tongue: English
Weight: 656 KB
Volume: 4
Category: Article
ISSN: 2157-1422
DOI: 10.1101/cshperspect.a019703

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of new treatment approaches

Development of new treatment approaches for epilepsy: Unmet needs and opportunities

✍ French, Jacqueline A.; White, H. Steve; Klitgaard, Henrik; Holmes, Gregory L.; P 📂 Article 📅 2013 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 206 KB

Prospects and challenges in anti-infecti

Prospects and challenges in anti-infective research and development: new drugs and approaches

✍ Harald Labischinski; Helga Ruebsamen-Waigmann 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 212 KB

New strategies in drug development and c

New strategies in drug development and clinical evaluation: the population approach

✍ L. P. Balant; M. Rowland; L. Aarons; F. Mentré; P. L. Morselli; J. L. Steimer; S 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 163 KB

PMDA’s Challenge to Accelerate Clinical

PMDA’s Challenge to Accelerate Clinical Development and Review of New Drugs in Japan

✍ Ichimaru, K; Toyoshima, S; Uyama, Y 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Education in Pharmaceutical Sciences Nee

Education in Pharmaceutical Sciences Needs a Brand New Direction to Meet the Challenges of Drug Research and Development

✍ Abu T. M. Serajuddin 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 289 KB

Drug Repositioning (Bringing New Life to

Drug Repositioning (Bringing New Life to Shelved Assets and Existing Drugs) || Opportunities and Challenges Associated with Developing Additional Indications for Clinical Development Candidates and Marketed Drugs

✍ Barratt, Michael J.; Frail, Donald E. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 104 KB

Drug Repositioning : The Business Case And Current Strategies To Repurpose Shelved Candidates And Marketed Drugs / John Arrowsmith And Richard Harrison -- Opportunities And Challenges Associated With Developing Additional Indications For Clinical Development Candidates And Marketed Drugs / Donald E.